HMX Pro Pharmacology: Drug Discovery and Development
INDP 646
Subject & Catalog Number
Course Information
Description
Drug discovery and development has evolved dramatically over recent decades and the field continues to advance today. More sophisticated approaches and models are being developed, new technology is being incorporated into the entire pipeline of development, and exciting drug modalities continue to emerge. With all the advances in science and with closer collaboration between different scientific disciplines, a multi-faceted approach is now being applied to drug discovery and development. Therefore, the likelihood of being able to discover a compound, transform this into a safe and effective therapeutic, and improve the lives of patients has increased.
Learning about the process of drug discovery and development has important implications for anyone working in healthcare and related sectors. This advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about how drugs are discovered and developed and about the advances happening in the field that are ultimately helping to improve the treatment and prevention of disease.
This is a fully online course. Students registering for this course will be automatically enrolled by HMX and will receive a confirmation email from onlinelearning@hms.harvard.edu three days prior to the HMX course start date. All course-related activities will happen through the HMX online platform. Students who complete the course will receive a Certificate of Completion. For more information please see the FAQ on the HMX website
https://learn.hms.harvard.edu/frequently-asked-questions and then click on the HMX ONLINE LEARNING link; register via my.harvard, do not use the “apply now” buttons on the HMX website.
Class Notes
Students must enroll in this course no later than September 8, 2026.
This course is intended for master's students only. Students must complete this course between September 8 and November 20, 2026.
Not Available for Cross Registration